SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-040317
Filing Date
2023-11-13
Accepted
2023-11-13 07:35:13
Documents
14
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35163
2 ex99-1.htm EX-99.1 124789
3 ex99-1_001.jpg GRAPHIC 25735
  Complete submission text file 0001493152-23-040317.txt   382692

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE celc-20231113.xsd EX-101.SCH 3015
5 XBRL LABEL FILE celc-20231113_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE celc-20231113_pre.xml EX-101.PRE 22789
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3373
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38207 | Film No.: 231395127
SIC: 8071 Services-Medical Laboratories